Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein. The ...

GlaxoSmithKline’s experimental malaria vaccine, RTS,S, has proved only 30% effective when administered to babies, as part of Africa’s largest ever clinical trial. There is a lot of pressure on ...

A team at GSK has identified what could be an entirely new weapon in the fight to eradicate malaria – but it isn't a new vaccine or antimalarial compound. Working with scientists at Johns ...

Expert Rev Vaccines. 2008;7(2):223-240. The EMVI is currently supporting preclinical activities at the Statens Serum Institute in Copenhagen and the Institut Pasteur in Paris for the development ...

Though considered a breakthrough, the new malaria vaccine isn't the first. A pilot program testing a GSK-produced vaccine in Africa resulted in a 13% decrease in deaths due to this disease among young ...

The adjuvant made from the soapbark tree is known in the industry as QS-21, and it is used in several vaccines approved by the US Food and Drug Administration, including Novavax’s COVID-19 shot and ...